Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Wanqiu Huang, Luyong Zhang & Zheng Li. (2022) Advances in computer-aided drug design for type 2 diabetes. Expert Opinion on Drug Discovery 17:5, pages 461-472.
Read now
Read now
Tafere Mulaw Belete. (2020) A Recent Achievement In the Discovery and Development of Novel Targets for the Treatment of Type-2 Diabetes Mellitus. Journal of Experimental Pharmacology 12, pages 1-15.
Read now
Read now
Zheng Li, Zongtao Zhou & Luyong Zhang. (2020) Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016–2019): a patent review. Expert Opinion on Therapeutic Patents 30:1, pages 27-38.
Read now
Read now
Jing-Jing Chen, Yu-Hang Gong & Ling He. (2019) Role of GPR40 in pathogenesis and treatment of Alzheimer's disease and type 2 diabetic dementia. Journal of Drug Targeting 27:4, pages 347-354.
Read now
Read now
Articles from other publishers (73)
Dapinder Pal Singh Loona, Bhanuranjan Das, Ramandeep Kaur, Rajnish Kumar & Ashok Kumar Yadav. (2023) Free Fatty Acid Receptors (FFARs): Emerging Therapeutic Targets
for the Management of Diabetes Mellitus. Current Medicinal Chemistry 30:30, pages 3404-3440.
Crossref
Crossref
Xiaojuan Zhang, David A. Ostrov & Haoming Tian. (2023) Taste Receptors Function as Nutrient Sensors in Pancreatic Islets: A
Potential Therapeutic Target for Diabetes. Endocrine, Metabolic & Immune Disorders - Drug Targets 23:9, pages 1137-1150.
Crossref
Crossref
Yingyu Lu, Wanlu Zhou, Qinghua Cui & Chunmei Cui. (2023) G Protein-Coupled Receptor 40 Agonist LY2922470 Alleviates Ischemic-Stroke-Induced Acute Brain Injury and Functional Alterations in Mice. International Journal of Molecular Sciences 24:15, pages 12244.
Crossref
Crossref
Bin Wang, Zongyu Cai, Huixin Yao, Shixuan Jiao, Siliang Chen, Zhongcheng Yang, Wanqiu Huang, Qiang Ren, Zhijun Cao, Ya Chen, Luyong Zhang & Zheng Li. (2023) Discovery of a structurally novel, potent, and once-weekly free fatty acid receptor 1 agonist for the treatment of diabetes. European Journal of Medicinal Chemistry 245, pages 114883.
Crossref
Crossref
Zheng Li, Lianru Chen & Luyong Zhang. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery
357
375
.
Michael Lückmann, Aslihan Shenol, Tinne A. D. NissenJacob E. Petersen, David Kouvchinov, Thue W. Schwartz & Thomas M. Frimurer. (2022) Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action. ACS Medicinal Chemistry Letters 13:12, pages 1839-1847.
Crossref
Crossref
Abdulrahman G. Alharbi, Andrew B. Tobin & Graeme Milligan. (2022) How Arrestins and GRKs Regulate the Function of Long Chain Fatty Acid Receptors. International Journal of Molecular Sciences 23:20, pages 12237.
Crossref
Crossref
Zongtao Zhou, Qiang Ren, Shixuan Jiao, Zongyu Cai, Xinqian Geng, Liming Deng, Bin Wang, Lijun Hu, Luyong Zhang, Ying Yang & Zheng Li. (2022) Discovery of new and highly effective quadruple FFA1 and PPARα/γ/δ agonists as potential anti-fatty liver agents. European Journal of Medicinal Chemistry 229, pages 114061.
Crossref
Crossref
Zongtao Zhou, Zongyu Cai, Congzi Zhang, Benhui Yang, Lianru Chen, Yepu He, Luyong Zhang & Zheng Li. (2022) Design, synthesis, and biological evaluation of novel dual FFA1 and PPARδ agonists possessing phenoxyacetic acid scaffold. Bioorganic & Medicinal Chemistry 56, pages 116615.
Crossref
Crossref
Bin Wang, Zongyu Cai, Siliang Chen, Ya Chen, Shixuan Jiao, Qiang Ren, Xuekun Wang, Xinqian Geng, Zheng Li & Guangji Wang. (2022) Design, synthesis, and biological evaluation of novel FFA1 partial agonists bearing oxime ether scaffold**. ChemistrySelect 7:2.
Crossref
Crossref
Angelo Maria Patti, Rosaria Vincenza Giglio, Nikolaos Papanas, Dragos Serban, Anca Pantea Stoian, Kalliopi Pafili, Khalid Al Rasadi, Kanya Rajagopalan, Ali A. Rizvi, Marcello Ciaccio & Manfredi Rizzo. (2022) Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes. Medicina 58:1, pages 109.
Crossref
Crossref
Mateusz Mach, Katarzyna Bazydło-Guzenda, Paweł Buda, Mikołaj Matłoka, Radosław Dzida, Filip Stelmach, Kinga Gałązka, Małgorzata Wąsińska-Kałwa, Damian Smuga, Dagmara Hołowińska, Urszula Dawid, Lidia Gurba-Bryśkiewicz, Krzysztof Wiśniewski, Krzysztof Dubiel, Jerzy Pieczykolan & Maciej Wieczorek. (2021) Discovery and development of CPL207280 as new GPR40/FFA1 agonist. European Journal of Medicinal Chemistry 226, pages 113810.
Crossref
Crossref
Ryokichi Koyama, Mitsugi Ookawara, Masanori Watanabe & Yusuke Moritoh. (2021) Chronic Exposure to SCO-267, an Allosteric GPR40 Full Agonist, Is Effective in Improving Glycemic Control in Rats. Molecular Pharmacology 99:4, pages 286-293.
Crossref
Crossref
Karina V. Sørensen, Svend S. Korfitzen, Mads H. Kaspersen, Elisabeth Rexen Ulven, Jeppe H. Ekberg, Annette Bauer-Brandl, Trond Ulven & Kurt Højlund. (2021) Acute effects of delayed-release hydrolyzed pine nut oil on glucose tolerance, incretins, ghrelin and appetite in healthy humans. Clinical Nutrition 40:4, pages 2169-2179.
Crossref
Crossref
Alexey Lukin, Anna Bakholdina, Nikolay Zhurilo, Oleksandra Onopchenko, Elena Zhuravel, Sergey Zozulya, Maxim Gureev, Alexander Safrygin & Mikhail Krasavin. (2020) Exploration of the nitrogen heterocyclic periphery around the core of the advanced FFA1 agonist fasiglifam (TAK‐875). Archiv der Pharmazie 354:4.
Crossref
Crossref
Liu Yang, Xian-Tao Lei, Qi Huang, Ting Wang, Hong-Bin Sun & He-Yao Wang. (2021) A novel GPR120-selective agonist promotes insulin secretion and improves chronic inflammation. Life Sciences 269, pages 119029.
Crossref
Crossref
Amit Gupta, Tapan Behl, Aayush Sehgal, Shaveta Bhardwaj, Sukhbir Singh, Neelam Sharma & Abdul Hafeez. (2021) Exploring the recent molecular targets for diabetes and associated complications. Molecular Biology Reports 48:3, pages 2863-2879.
Crossref
Crossref
Lata Rani, Ajmer Singh Grewal, Neelam Sharma & Sukhbir Singh. (2021) Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus. Mini-Reviews in Medicinal Chemistry 21:4, pages 426-470.
Crossref
Crossref
Manuel Grundmann, Eckhard Bender, Jens Schamberger & Frank Eitner. (2021) Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators. International Journal of Molecular Sciences 22:4, pages 1763.
Crossref
Crossref
A. W. Moran, K. Daly, M. A. Al-Rammahi & S. P. Shirazi-Beechey. (2020) Nutrient sensing of gut luminal environment. Proceedings of the Nutrition Society 80:1, pages 29-36.
Crossref
Crossref
Julien Ghislain & Vincent Poitout. (2021) Targeting lipid GPCRs to treat type 2 diabetes mellitus — progress and challenges. Nature Reviews Endocrinology.
Crossref
Crossref
Najeeb Shah, Mohammed Altigani Abdalla, Harshal Deshmukh & Thozhukat Sathyapalan. (2021) Therapeutics for type-2 diabetes mellitus: a glance at the recent inclusions and novel agents under development for use in clinical practice. Therapeutic Advances in Endocrinology and Metabolism 12, pages 204201882110421.
Crossref
Crossref
S. O. Kuranov, O. A. Luzina & N. F. Salakhutdinov. (2020) FFA1 (GPR40) Receptor Agonists Based on Phenylpropanoic Acid as Hypoglycemic Agents: Structure–Activity Relationship. Russian Journal of Bioorganic Chemistry 46:6, pages 972-988.
Crossref
Crossref
Lijun Hu, Zongtao Zhou, Liming Deng, Qiang Ren, Zongyu Cai, Bin Wang, Zheng Li & Guangji Wang. (2020) HWL-088, a new and highly effective FFA1/PPARδ dual agonist, attenuates nonalcoholic steatohepatitis by regulating lipid metabolism, inflammation and fibrosis. Journal of Pharmacy and Pharmacology 72:11, pages 1564-1573.
Crossref
Crossref
Zheng Li, Zongtao Zhou, Lijun Hu, Liming Deng, Qiang Ren & Luyong Zhang. (2020) ZLY032, the first-in-class dual FFA1/PPARδ agonist, improves glucolipid metabolism and alleviates hepatic fibrosis. Pharmacological Research 159, pages 105035.
Crossref
Crossref
Zhiwen Ye, Chunxia Liu, Feng Zou, Yan Cai, Bin Chen, Yuxing Zou, Jiaxian Mo, Ting Han, Wenlong Huang, Qianqian Qiu & Hai Qian. (2020) Discovery of novel potent GPR40 agonists containing imidazo[1,2-a]pyridine core as antidiabetic agents. Bioorganic & Medicinal Chemistry 28:13, pages 115574.
Crossref
Crossref
Qinghong Shi, Yang Liu, Chunyan Liu & Jingying Wang. (2020) Characterization of the metabolites of TUG‐891 in rat, dog, and human hepatocytes using ultra‐high‐performance liquid chromatography tandem mass spectrometry and nuclear magnetic resonance spectroscopy. Rapid Communications in Mass Spectrometry 34:11.
Crossref
Crossref
Yueming Chen, Qiang Ren, Zongtao Zhou, Liming Deng, Lijun Hu, Luyong Zhang & Zheng Li. (2020)
HWL‐088, a new potent free fatty acid receptor 1 (FFAR1) agonist, improves glucolipid metabolism and acts additively with metformin in
ob/ob
diabetic mice
. British Journal of Pharmacology 177:10, pages 2286-2302.
Crossref
Crossref
Krishna A. Gajjar & Anuradha K. Gajjar. (2020) CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators. Current Drug Discovery Technologies 17:1, pages 100-118.
Crossref
Crossref
Ruth E. Gimeno, Daniel A. Briere & Randy J. Seeley. (2020) Leveraging the Gut to Treat Metabolic Disease. Cell Metabolism 31:4, pages 679-698.
Crossref
Crossref
Zheng Li, Chunxia Liu, Zongtao Zhou, Lijun Hu, Liming Deng, Qiang Ren & Hai Qian. (2020) A novel FFA1 agonist, CPU025, improves glucose-lipid metabolism and alleviates fatty liver in obese-diabetic (ob/ob) mice. Pharmacological Research 153, pages 104679.
Crossref
Crossref
Chunlei Wang, Yanmei Liu, Yuan Pan & Hui Jin. (2020)
Effect of GSK-137647A, the first non-carboxylic FFA4 agonist, on the osteogenic and adipogenic differentiation of bone mesenchymal stem cells in
db/db
mice
. Journal of Pharmacy and Pharmacology 72:3, pages 461-469.
Crossref
Crossref
J. Kleemann, I. Hrgovic, P. Kleimann, J. Ter‐Nedden, M. Glaser, K. Steinhorst, K. Härle, J. Müller, R. Kaufmann, S. Kippenberger & M. Meissner. (2019)
G protein‐coupled receptor 40 expression in human melanoma – correlation with tumour thickness,
AJCC
stage and survival
. Journal of the European Academy of Dermatology and Venereology 34:2, pages 285-292.
Crossref
Crossref
Ikuo Kimura, Atsuhiko Ichimura, Ryuji Ohue-Kitano & Miki Igarashi. (2020) Free Fatty Acid Receptors in Health and Disease. Physiological Reviews 100:1, pages 171-210.
Crossref
Crossref
Patricio Atanes & Shanta J. Persaud. 2020. GPCRs. GPCRs
367
391
.
Xiao-Fang Mao, Hai-Yun Wu, Xue-Qi Tang, Usman Ali, Hao Liu & Yong-Xiang Wang. (2019) Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/β-endorphin pathway. Journal of Neuroinflammation 16:1.
Crossref
Crossref
Zheng Li, Lijun Hu, Xuekun Wang, Zongtao Zhou, Liming Deng, Yawen Xu & Luyong Zhang. (2019) Design, synthesis, and biological evaluation of novel dual FFA1 (GPR40)/PPARδ agonists as potential anti-diabetic agents. Bioorganic Chemistry 92, pages 103254.
Crossref
Crossref
Zheng Li, Qiang Ren, Xuekun Wang, Zongtao Zhou, Lijun Hu, Liming Deng, Li Guan & Qianqian Qiu. (2019) Discovery of HWL-088: A highly potent FFA1/GPR40 agonist bearing a phenoxyacetic acid scaffold. Bioorganic Chemistry 92, pages 103209.
Crossref
Crossref
Zheng Li, Chunxia Liu, Jianyong Yang, Jiaqi Zhou, Zhiwen Ye, Dazhi Feng, Na Yue, Jiayi Tong, Wenlong Huang & Hai Qian. (2019) Design, synthesis and biological evaluation of novel FFA1/GPR40 agonists: New breakthrough in an old scaffold. European Journal of Medicinal Chemistry 179, pages 608-622.
Crossref
Crossref
Kai Iwata, Hiromichi Sakai, Daisuke Takahashi & Fumio Sakane. (2019) Myristic acid specifically stabilizes diacylglycerol kinase δ protein in C2C12 skeletal muscle cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1864:7, pages 1031-1038.
Crossref
Crossref
Yu Li, Xue Yang, Hui Zhang & Qiuhong Wu. (2019) Pharmacokinetics and metabolism of GW9508 in rat by liquid chromatography/electrospray ionization tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 170, pages 176-186.
Crossref
Crossref
Chulhun Park, Nileshkumar Meghani, Hardik Amin, Phuong H.-L. Tran, Thao T.-D. Tran, Van H. Nguyen & Beom-Jin Lee. (2019) The roles of short and long chain fatty acids on physicochemical properties and improved cancer targeting of albumin-based fattigation-platform nanoparticles containing doxorubicin. International Journal of Pharmaceutics 564, pages 124-135.
Crossref
Crossref
Bing Liu, Liming Deng, Haidong Chen, Ruoxian Liao, Yuyi Li, Xiaohua Zeng, Fengjian Deng, Luyong Zhang & Zheng Li. (2019) Design, synthesis and biological activity of deuterium-based FFA1 agonists with improved pharmacokinetic profiles. Bioorganic & Medicinal Chemistry Letters 29:12, pages 1471-1475.
Crossref
Crossref
Lisandro Jorge Falomir-Lockhart, Gian Franco Cavazzutti, Ezequiel Giménez & Andrés Martín Toscani. (2019) Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors. Frontiers in Cellular Neuroscience 13.
Crossref
Crossref
Michael Lückmann, Mette Trauelsen, Marie A. Bentsen, Tinne A. D. Nissen, Joao Martins, Zohreh Fallah, Mads M. Nygaard, Elena Papaleo, Kresten Lindorff-Larsen, Thue W. Schwartz & Thomas M. Frimurer. (2019) Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1. Proceedings of the National Academy of Sciences 116:14, pages 7123-7128.
Crossref
Crossref
Deyu Kong, Shimeng Guo, Yushe Yang, Bin Guo, Xin Xie & Wenhao Hu. (2019) Synthesis and biological evaluation of novel potent FFA1 agonists containing 2,3-dihydrobenzo[b][1,4]dioxine. Bioorganic & Medicinal Chemistry Letters 29:6, pages 848-852.
Crossref
Crossref
Zheng Li, Yueming Chen, Zongtao Zhou, Liming Deng, Yawen Xu, Lijun Hu, Bing Liu & Luyong Zhang. (2019) Discovery of first-in-class thiazole-based dual FFA1/PPARδ agonists as potential anti-diabetic agents. European Journal of Medicinal Chemistry 164, pages 352-365.
Crossref
Crossref
Martin Audet & Raymond C. Stevens. (2019) Emerging structural biology of lipid G protein‐coupled receptors. Protein Science 28:2, pages 292-304.
Crossref
Crossref
Bin Guo, Shimeng Guo, Jing Huang, Jingya Li, Jia Li, Qian Chen, Xianli Zhou, Xin Xie & Yushe Yang. (2018) Design and optimization of 2,3-dihydrobenzo[b][1,4]dioxine propanoic acids as novel GPR40 agonists with improved pharmacokinetic and safety profiles. Bioorganic & Medicinal Chemistry 26:22, pages 5780-5791.
Crossref
Crossref
Zheng Li, Zongtao Zhou, Fengjian Deng, Yuyi Li, Danjun Zhang & Luyong Zhang. (2018) Design, synthesis, and biological evaluation of novel pan agonists of FFA1, PPARγ and PPARδ. European Journal of Medicinal Chemistry 159, pages 267-276.
Crossref
Crossref
Chandan Sona, Ajeet Kumar, Shalini Dogra, Boda Arun Kumar, Deepmala Umrao & Prem N. Yadav. (2018) Docosahexaenoic acid modulates brain-derived neurotrophic factor via GPR40 in the brain and alleviates diabesity-associated learning and memory deficits in mice. Neurobiology of Disease 118, pages 94-107.
Crossref
Crossref
Zheng Li, Yueming Chen, Yuhan Zhang, Hongwei Jiang, Yanzhi Liu, Yufang Chen, Luyong Zhang & Hai Qian. (2018) Structure-based design of free fatty acid receptor 1 agonists bearing non-biphenyl scaffold. Bioorganic Chemistry 80, pages 296-302.
Crossref
Crossref
Chunxia Liu, Zheng Li, Wei Shi, Huilan Li, Nasi Wang, Yuxuan Dai, Chen Liao, Wenlong Huang & Hai Qian. (2018)
Improving metabolic stability with deuterium: The discovery of
HWL
‐066, a potent and long‐acting free fatty acid receptor 1 agonists
. Chemical Biology & Drug Design 92:2, pages 1547-1554.
Crossref
Crossref
Zheng Li, Xue Xu, Roujia Liu, Fengjian Deng, Xiaohua Zeng & Luyong Zhang. (2018) Nitric oxide donor-based FFA1 agonists: Design, synthesis and biological evaluation as potential anti-diabetic and anti-thrombotic agents. Bioorganic & Medicinal Chemistry 26:15, pages 4560-4566.
Crossref
Crossref
Carlota RecioDaniel LucyPoppy IvesonAsif J. IqbalSophia ValarisGraham WynneAngela J. RussellRobin P. ChoudhuryChris O'CallaghanClaudia MonacoDavid R. Greaves. (2018) The Role of Metabolite-Sensing G Protein-Coupled Receptors in Inflammation and Metabolic Disease. Antioxidants & Redox Signaling 29:3, pages 237-256.
Crossref
Crossref
Marie-Laure Rives, Brian Rady, Nadia Swanson, Shuyuan Zhao, Jenson Qi, Eric Arnoult, Ivona Bakaj, Arturo Mancini, Billy Breton, S. Paul Lee, Mark R. Player & Alessandro Pocai. (2018)
GPR40-Mediated G
α
12 Activation by Allosteric Full Agonists Highly Efficacious at Potentiating Glucose-Stimulated Insulin Secretion in Human Islets
. Molecular Pharmacology 93:6, pages 581-591.
Crossref
Crossref
Chinedum Eleazu, Ayogu Charles, Kate Eleazu & Ngozi Achi. (2018) Free fatty acid receptor 1 as a novel therapeutic target for type 2 diabetes mellitus-current status. Chemico-Biological Interactions 289, pages 32-39.
Crossref
Crossref
Zheng Li, Xue Xu, Jie Hou, Shaohong Wang, Hongwei Jiang & Luyong Zhang. (2018) Structure-based optimization of free fatty acid receptor 1 agonists bearing thiazole scaffold. Bioorganic Chemistry 77, pages 429-435.
Crossref
Crossref
Michael P. Winters, Zhihua Sui, Mark Wall, Yuanping Wang, Joseph Gunnet, James Leonard, Hong Hua, Wen Yan, Arthur Suckow, Austin Bell, Wilmelenne Clapper, Celia Jenkinson, Peter Haug, Tatiana Koudriakova, Norman Huebert & William V. Murray. (2018) Discovery of N -arylpyrroles as agonists of GPR120 for the treatment of type II diabetes. Bioorganic & Medicinal Chemistry Letters 28:5, pages 841-846.
Crossref
Crossref
Zheng Li, Xue Xu, Wenlong Huang & Hai Qian. (2018) Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges. Medicinal Research Reviews 38:2, pages 381-425.
Crossref
Crossref
Zheng Li, Chunxia Liu, Wei Shi, Xingguang Cai, Yuxuan Dai, Chen Liao, Wenlong Huang & Hai Qian. (2018) Identification of highly potent and orally available free fatty acid receptor 1 agonists bearing isoxazole scaffold. Bioorganic & Medicinal Chemistry 26:3, pages 703-711.
Crossref
Crossref
Zheng Li, Chunxia Liu, Xue Xu, Wei Shi, Huilan Li, Yuxuan Dai, Xingguang Cai, Wenlong Huang & Hai Qian. (2018) Design, synthesis, and biological evaluation of deuterated phenylpropionic acid derivatives as potent and long-acting free fatty acid receptor 1 agonists. Bioorganic Chemistry 76, pages 303-313.
Crossref
Crossref
Zheng Li, Xue Xu, Gang Li, Xiaoting Fu, Yanzhi Liu, Yufeng Feng, Mingyan Wang, Yunting Ouyang & Jing Han. (2017) Improving metabolic stability with deuterium: The discovery of GPU-028, a potent free fatty acid receptor 4 agonists. Bioorganic & Medicinal Chemistry 25:24, pages 6647-6652.
Crossref
Crossref
Zheng Li, Chunxia Liu, Xue Xu, Qianqian Qiu, Xin Su, Yuxuan Dai, Jianyong Yang, Huilan Li, Wei Shi, Chen Liao, Miaobo Pan, Wenlong Huang & Hai Qian. (2017) Discovery of phenylsulfonyl acetic acid derivatives with improved efficacy and safety as potent free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. European Journal of Medicinal Chemistry 138, pages 458-479.
Crossref
Crossref
Kenneth R. Watterson, Steffen V. F. Hansen, Brian D. Hudson, Elisa Alvarez-Curto, Sheikh Zahir Raihan, Carlos M. G. Azevedo, Gabriel Martin, Julia Dunlop, Stephen J. Yarwood, Trond Ulven & Graeme Milligan. (2017) Probe-Dependent Negative Allosteric Modulators of the Long-Chain Free Fatty Acid Receptor FFA4. Molecular Pharmacology 91:6, pages 630-641.
Crossref
Crossref
Julia M. Houthuijzen, Ilse Oosterom, Brian D. Hudson, Akira Hirasawa, Laura G. M. Daenen, Chelsea M. McLean, Steffen V. F. Hansen, Marijn T. M. Jaarsveld, Daniel S. Peeper, Sahar Jafari Sadatmand, Jeanine M. L. Roodhart, Chris H. A. Lest, Trond Ulven, Kenji Ishihara, Graeme Milligan & Emile E. Voest. (2017) Fatty acid 16:4(n‐3) stimulates a GPR120‐induced signaling cascade in splenic macrophages to promote chemotherapy resistance.. The FASEB Journal 31:5, pages 2195-2209.
Crossref
Crossref
He Li, Qi Huang, Cheng Chen, Bin Xu, He-Yao Wang & Ya-Qiu Long. (2017) Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold. Journal of Medicinal Chemistry 60:7, pages 2697-2717.
Crossref
Crossref
Jianyong Yang, Zheng Li, Huilan Li, Chunxia Liu, Nasi Wang, Wei Shi, Chen Liao, Xingguang Cai, Wenlong Huang & Hai Qian. (2017) Design, synthesis and structure–activity relationship studies of novel free fatty acid receptor 1 agonists bearing amide linker. Bioorganic & Medicinal Chemistry 25:8, pages 2445-2450.
Crossref
Crossref
Mikhail Krasavin, Alexey Lukin, Daria Bagnyukova, Nikolay Zhurilo, Aleksei Golovanov, Sergey Zozulya, Ihor Zahanich, Daniel Moore & Irina G. Tikhonova. (2017) Polar aromatic periphery increases agonist potency of spirocyclic free fatty acid receptor (GPR40) agonists inspired by LY2881835. European Journal of Medicinal Chemistry 127, pages 357-368.
Crossref
Crossref
Gregory L. Adams, Francisco Velazquez, Charles Jayne, Unmesh Shah, Shouwu Miao, Eric R. Ashley, Maria Madeira, Taro E. Akiyama, Jerry Di Salvo, Takao Suzuki, Nengxue Wang, Quang Truong, Eric Gilbert, Dan Zhou, Andreas Verras, Melissa Kirkland, Michele Pachanski, Maryann Powles, Wu Yin, Feroze Ujjainwalla, Srikanth Venkatraman & Scott D. Edmondson. (2016)
Discovery of Chromane Propionic Acid Analogues as Selective Agonists of GPR120 with
in Vivo
Activity in Rodents
. ACS Medicinal Chemistry Letters 8:1, pages 96-101.
Crossref
Crossref
J. M. Houthuijzen. (2016) For Better or Worse: FFAR1 and FFAR4 Signaling in Cancer and Diabetes. Molecular Pharmacology 90:6, pages 738-743.
Crossref
Crossref
Elisa Alvarez-Curto, Asuka Inoue, Laura Jenkins, Sheikh Zahir Raihan, Rudi Prihandoko, Andrew B. Tobin & Graeme Milligan. (2016) Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling. Journal of Biological Chemistry 291:53, pages 27147-27159.
Crossref
Crossref
Zheng Li, Jianyong Yang, Xuekun Wang, Huilan Li, Chunxia Liu, Nasi Wang, Wenlong Huang & Hai Qian. (2016) Discovery of novel free fatty acid receptor 1 agonists bearing triazole core via click chemistry. Bioorganic & Medicinal Chemistry 24:21, pages 5449-5454.
Crossref
Crossref